Publicaciones en colaboración con investigadores/as de Hospital Universitario Virgen de la Victoria (13)

2024

  1. Is There an Opportunity to De-Escalate Treatments in Selected Patients with Metastatic Hormone-Sensitive Prostate Cancer?

    Cancers, Vol. 16, Núm. 13

  2. MR-LINAC, a New Partner in Radiation Oncology: Current Landscape

    Cancers, Vol. 16, Núm. 2

  3. Total Neoadjuvant Therapy Approach for the Treatment of Locally Advanced Rectal Cancer: Where Do We Stand?

    Oncology (Switzerland), Vol. 102, Núm. 7, pp. 646-657

2023

  1. Coronavirus disease 2019 and lung cancer: where are we?

    Exploration of Targeted Anti-tumor Therapy, Vol. 4, Núm. 5, pp. 1082-1094

  2. Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Factors in Locally Advanced Rectal Cancer

    Oncology (Switzerland), Vol. 101, Núm. 6, pp. 349-357

  3. Novel Approaches in the Systemic Management of High-Risk Prostate Cancer

    Clinical Genitourinary Cancer, Vol. 21, Núm. 6, pp. e485-e494

  4. Oligometastatic Hormone-Sensitive Prostate Cancer. Why Radiotherapy?

    Clinical Genitourinary Cancer, Vol. 21, Núm. 3, pp. e93-e103

  5. Prostate Cancer: Management of Biochemical Recurrence after Surgery

    Archivos espanoles de urologia, Vol. 76, Núm. 10, pp. 733-745

  6. Role of Radiotherapy and Hormone Therapy in Patients with Node-Positive Locally Advanced Prostate Cancer

    Archivos espanoles de urologia, Vol. 76, Núm. 10, pp. 718-732

  7. Stereotactic body radiation therapy for kidney cancer. Where do we stand?

    International Journal of Urology, Vol. 30, Núm. 5, pp. 437-445

2022

  1. Bone health and therapeutic agents in advanced prostate cancer

    Frontiers in Bioscience - Landmark, Vol. 27, Núm. 1

  2. IJRadiation therapy for recurrent hydatid cyst of the pelvic bone: a case report

    International Journal of Infectious Diseases, Vol. 115, pp. 168-170

  3. Immunotherapy in Advanced Prostate Cancer: Current Knowledge and Future Directions

    Biomedicines, Vol. 10, Núm. 3